Imaging DNA synthesis in vivo with 18F-FMAU and PET.

作者: Otto Muzik , Thomas J. Mangner , Jerry M. Collins , Kirk Douglas , Haihao Sun

DOI:

关键词: LymphDNA synthesisExcretionBiochemistrySmall intestineBone marrowBiodistributionThymidineChemistryIn vivo

摘要: We imaged DNA synthesis in vivo with PET and 1 8 F-1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)thymine (FMAU), which is phosphorylated by thymidine kinases incorporated into DNA. Methods: produced F-FMAU injected the tracer 5 normal dogs studied them imaging or biodistribution for up to 2.5 h. The pharmacokinetics of FMAU blood urine were determined using high-performance liquid chromatography analysis. At end each study, selected tissues removed measure total activity retained these tissues. In addition, extracted acid precipitation, macromolecules can be precipitated determine radioactivity Results: Imaging tissue analysis showed increased lymph nodes, stomach, small intestine, bone marrow, mean standardized uptake values 1.4, 1.6, 2.3, 3.9, respectively, because varying degrees cell proliferation. contrast, was distributed tissue-to-muscle ratios approximately 1.0 nonproliferative organs such as lung, liver, kidneys. Analysis extracts precipitation demonstrated that 88% marrow 65% intestine precipitated. However, more than 90% nonproliferating heart lungs supernatant. Increased seen a high level kinase 2 gallbladder excretion. 95% present intact at studies. Conclusion: results selectively proliferating resistant degradation. These features indicate might an alternative C-thymidine tumors.

参考文章(23)
Christoph Nerl, Christoph Fuchs, Sibylle Ziegler, Markus Schwaiger, Wolfgang Römer, Axel-R. Hanauske, Wolfgang Weber, Ralf Thödtmann, Manfred Garbrecht, Wolfgang Enne, Michael Herz, Positron Emission Tomography in Non-Hodgkin's Lymphoma: Assessment of Chemotherapy With Fluorodeoxyglucose Blood. ,vol. 91, pp. 4464- 4471 ,(1998) , 10.1182/BLOOD.V91.12.4464
J. Buchanan, Richard L. Wahl, Principles and Practice of Positron Emission Tomography ,(2002)
J L Sherley, T J Kelly, Regulation of human thymidine kinase during the cell cycle Journal of Biological Chemistry. ,vol. 263, pp. 8350- 8358 ,(1988) , 10.1016/S0021-9258(18)68484-4
Ichiei Kuji, Lale Kostakoglu, Stanley J. Goldsmith, Morton Coleman, John P. Leonard, Holly Zoe, PET Predicts Prognosis After 1 Cycle of Chemotherapy in Aggressive Lymphoma and Hodgkin’s Disease The Journal of Nuclear Medicine. ,vol. 43, pp. 1018- 1027 ,(2002)
Takayuki Kuriyama, Hiroshi Kitahara, Koichiro Tatsumi, Yoshihito Yamada, Hiroshi Kimura, Yoshitaka Uchida, Tetsuo Yamaguchi, Fluorine-18-fluorodeoxyglucose and carbon-11-methionine evaluation of lymphadenopathy in sarcoidosis. The Journal of Nuclear Medicine. ,vol. 39, pp. 1160- 1166 ,(1998)
Anthony F. Shields, John R. Grierson, Bernhard M. Dohmen, H.-Juergen Machulla, Joseph C. Stayanoff, Jawana M. Lawhorn-Crews, Joyce E. Obradovich, Otto Muzik, Thomas J. Mangner, Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nature Medicine. ,vol. 4, pp. 1334- 1336 ,(1998) , 10.1038/3337
J.M. Ollinger, J.A. Fessler, Positron-emission tomography IEEE Signal Processing Magazine. ,vol. 14, pp. 43- 55 ,(1997) , 10.1109/79.560323
W. Lewis, E. S. Levine, B. Griniuviene, K. O. Tankersley, J. M. Colacino, J. P. Sommadossi, K. A. Watanabe, F. W. Perrino, Fialuridine and its metabolites inhibit DNA polymerase gamma at sites of multiple adjacent analog incorporation, decrease mtDNA abundance, and cause mitochondrial structural defects in cultured hepatoblasts. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 93, pp. 3592- 3597 ,(1996) , 10.1073/PNAS.93.8.3592
JamesL. Abbruzzese, Susan Schmidt, MartinN. Raber, JoelK. Levy, AugustinM. Castellanos, SewaS. Legha, IrwinH. Krakoff, Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU) terminated by severe neurologic toxicity Investigational New Drugs. ,vol. 7, pp. 195- 201 ,(1989) , 10.1007/BF00170857